Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study

Background and Purpose: Apatinib is a novel antiangiogenic agent that can target vascular endothelial cell growth factor 2. The aim of our study was to evaluate the efficacy and safety of apatinib mesylate in the treatment of advanced hepatocellular carcinoma (HCC) in the real world.Methods: We retr...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhuangzhuang Zheng, Zijing Liu, Haifeng Zhang, Xiao Guo, Xiaojing Jia, Jianfeng Wang, Lingbin Meng, Ying Xin, Xin Jiang
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Pharmacology
Subjects:
apatinib
hepatocellular carcinoma
vascular endothelial growth factor-2 (VEGFR-2)
transcatheter arterial chemoembolization (TACE)
progression-free survival
overall survival
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.894016/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Loading...

Similar Items